SMYD3 levels in HCC were also analyzed in TCGA dataset, confirming that its upregulation is correlated with the development of new tumor foci, HCC progression to high-grade disease and poorer overall survival [11]. Here, SMYD3 is linked to hepatocellular carcinoma.